| 1 |
31740054 | Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis. | 2020 Jan 15 |
1 |
| 2 |
30075004 | The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases. | 2018 |
1 |
| 3 |
26638045 | Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors. | 2016 Jan 27 |
1 |
| 4 |
25921268 | New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids. | 2015 Jul 1 |
1 |
| 5 |
22257051 | MMP-2 selectivity in hydroxamate-type inhibitors. | 2012 |
1 |
| 6 |
21219645 | LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells. | 2011 Jan 10 |
1 |
| 7 |
17333483 | Improved estimation of ligand-macromolecule binding affinities by linear response approach using a combination of multi-mode MD simulation and QM/MM methods. | 2007 Jan-Mar |
1 |
| 8 |
12811828 | Modulation of PAI-1 and proMMP-9 syntheses by soluble TNFalpha and its receptors during differentiation of the human monocytic HL-60 cell line. | 2003 Aug |
1 |
| 9 |
12051944 | Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. | 2002 May 24 |
2 |
| 10 |
10415825 | Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor. | 1999 Jun 30 |
1 |